Evofem Biosciences Inc (EVFM)

NASDAQ
0.4051
-0.6949(-63.17%)
After Hours
0.4097
+0.0046(+1.1355%)
- Real-time Data
  • Volume:
    21,112,700
  • Day's Range:
    0.4000 - 0.5001
  • 52 wk Range:
    0.4000 - 21.3000

EVFM Overview

Prev. Close
1.1
Day's Range
0.4-0.5001
Revenue
11.39M
Open
0.495
52 wk Range
0.4-21.3
EPS
-18.97
Volume
21,112,700
Market Cap
5.95M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
622,664
P/E Ratio
-
Beta
0.41
1-Year Change
-96.77%
Shares Outstanding
14,677,526
Next Earnings Date
Aug 09, 2022
What is your sentiment on Evofem Biosciences?
or
Market is currently closed. Voting is open during market hours.

Evofem Biosciences Inc News

Evofem Biosciences Inc Analysis

Evofem Biosciences Inc Company Profile

Evofem Biosciences Inc Company Profile

Employees
119

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • new public offer at 0.75 USD right after R/S, this company is a scam or management doesn't know what to do and how come that a company can make a an offer at lower price that the minimum compliant price at exchange where they are listed? I know Stock Market is a risky business, but now I think it is just a big gamble all the way where everybody can do anything with amateur investors' money
    0
    • https://www.barrons.com/articles/investigation-alert-fields-kupka-shukurov-llp-is-investigating-evofem-biosciences-inc-for-potential-breach-of-fiduciary-duty-claims-01648739723
      1
      • That one was closed a long time ago. But ofcourse you knew that.
        0
    • https://www.barrons.com/articles/investigation-alert-fields-kupka-shukurov-llp-is-investigating-evofem-biosciences-inc-for-potential-breach-of-fiduciary-duty-claims-01648739723
      1
      • R/S split happened, usually it is bad sign right? :(
        0
        • Not good at least. But kinda they were forced into it this time to avoid delisting.
          0
      • https://www.change.org/p/fire-evofem-bioscences-ceo-stop-cash-burn-and-reject-stock-reverse-split
        1
        • incase anyone is interested: I've read on several platforms the past few days that $MULN is going to takeoff -GME/AMC esque- I'm gonna get in to see if I can make up some of my losses with EVFM. I'm not an advisor nor do I really know a whole lot about MULN but I do know that historically, when I've seen the chatter like I am with MULN the stock jumps up significantly
          3
          • the team there couldn't organize a 1 person parade....
            1
            • someone just posted this elsewhere and I thought I would share Eight stocks primed for a short squeeze in March:Tattooed Chef Inc. (TTCF)Ginkgo Bioworks Holdings Inc. (DNA)Weber Inc. (WEBR)Blink Charging Co. (BLNK)Vicarious Surgical Inc. (RBOT)EVgo Inc. (EVGO)Velo3D Inc. (VLD)Evofem Biosciences Inc. (EVFM)Mar 2, 2022
              1
              • Reverse split is loading :)
                1
                • Useless management, zoom out. They can't execute.
                  3
                  • Seems they can though.
                    0
                  • Lets hope. We need to see real improve not just talking
                    0